Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 335

The DOI matches its OpenAlex record; 39 of the 39 references it cites were found in a registry or an index.

Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes

Thomas A. Buchanan · 2001 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia that results from tissue resistance to the glucose-lowering effects of insulin and inadequate pancreatic B-cell compensation for that resistance (1). Longitudinal studies of people at risk for T2DM reveal that insulin resistance is often present years before the onset of hyperglycemia (2–4). Studies of the evolution of diabetes during a relatively short period (i.e. 5–7 yr) before the diagnosis in Mexican Americans and Pima Indians have revealed that: 1) poor B-cell function and insulin resistance precede and predict the development of diabetes (4, 6); and 2) the progression from normal glucose tolerance to diabetes is attended by a decline in B-cell function and an increase in insulin resistance (6). These findings indicate that insulin resistance and B-cell dysfunction both occur in people who develop T2DM. They do not reveal whether declining B-cell function is an independent event that is simply coincident with insulin resistance in some members of the population or whether the two abnormalities are causally linked. Here, I will develop the theme that insulin resistance causes B-cell dysfunction in susceptible individuals, using information from women who are at increased risk for T2DM by virtue of a clinical diagnosis of gestational diabetes. B-cell function can be assessed by quantifying insulin responses to nutrients or by characterizing the composition of the peptide mix released by B-cells (e.g. proinsulin to insulin ratios) (7), or temporal patterns of insulin release (e.g. pulsatility; Refs. 8 and 9). Relatively little work has been done on the latter two areas in women with gestational diabetes mellitus (GDM). Some investigators have reported an increase in the ratio of proinsulin to insulin in the circulation of women with GDM (10). Others have failed to find such a difference (11). Here, the focus will be on B-cell function as assessed by quantitative insulin responses to nutrients. In 1981, Bergman et al. (12) proposed that there is a predictable relationship, in the shape of a rectangular hyperbola, between the quantity of insulin produced by B cells and the sensitivity of tissues to the glucose-lowering effects of that insulin. Kahn et al. (13) demonstrated that such a relationship is present across a wide range of insulin sensitivity in people with normal glucose tolerance. We found a hyperbolic relationship between insulin sensitivity and several measures of B-cell insulin release in women with impaired glucose tolerance (14). The amount of insulin released at a given level of insulin resistance is lower in people with abnormal compared with normal glucose tolerance (15). The general concept of hyperbolic relationships between insulin sensitivity and B-cell insulin release is depicted in the left panel of Fig. 1. Each curved line (hyperbola) represents an isobar of B-cell compensation for ambient insulin resistance. Individuals whose sensitivity-secretion relationships lie on the same line have the same level of B-cell compensation. To the extent that insulin sensitivity and insulin release are the main determinants of glycemia, individuals on the same line will also have the same or very similar plasma glucose levels and glucose tolerance. People whose B-cell function worsens over time should move from a more favorable to a less favorable sensitivity-secretion relationship—movement down and to the left in Fig. 1. Longitudinal studies in Pima Indians indicate that such movement (i.e. increasing insulin resistance with decreasing B-cell function; Ref. 6) does occur over the course of years during progression from normal glucose tolerance to T2DM. Left, Schematic representation of hyperbolic relationships between insulin sensitivity and insulin secretion in groups with different levels of glycemia. Right, Expected and observed insulin secretion in two groups of individuals with normal or impaired glucose tolerance. Differences in insulin sensitivity predict differences in insulin secretion. Insulin secretion is the same in the two groups, indicating a large B-cell defect in the group with impaired glucose tolerance. The right panel of Fig. 1 demonstrates the pitfalls that may be encountered when comparing quantitative aspects of B-cell function between individuals or groups with different levels of insulin sensitivity. Two groups that differ in their degree of insulin resistance should also differ in quantitative B-cell responses to glucose or other nutrients. If they fail to do so, as is true for the groups depicted in the right panel of Fig. 1, then they have different B-cell function (i.e. different compensation for ambient insulin resistance). The best way to compare B-cell function between such groups in a quantitative fashion is to determine whether their sensitivity-secretion relationships are on the same or different hyperbolic lines. Taking advantage of the mathematical formula of a rectangular hyperbola (y = × * k,

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1210/jc.86.3.989

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 335

Metadata

Authors
Buchanan, T. A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
Oxford University Press
Published
2001-03-01
Volume
86
Issue
3
Pages
989-993
ISSN
0021-972X (ISSN-L)
OpenAlex
W1988760852
Cited by
335
References
39
FWCI
11.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/jc.86.3.989
The paper
Buchanan, T. A. (2001). Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.86.3.989

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.